# Shubhra Jain

> Dr. Shubhra Jain, MD, MBA is Chief Business Officer at Hippocratic AI, the $3.5B generative AI healthcare company building the world's safest patient-facing AI agents. A rare triple threat - trained primary care physician, Stanford engineer (MS Biodesign), and Wharton MBA - she brings a decade of healthcare investing and product leadership to Hippocratic AI's commercial strategy. Before joining HAI, she led healthcare investing at Tarsadia Investments and Cota Capital, and held product leadership roles at Natera and Pieces Technologies. A first-generation immigrant from a small Indian town, she is a passionate advocate for health equity, underrepresented founders, and making healthcare abundant for all.

- **Role:** Chief Business Officer at Hippocratic AI
- **Organizations:** Hippocratic AI, Tarsadia Investments, Cota Capital, Natera, Pieces Technologies
- **From:** India
- **Nationality:** American (Indian-origin)
- **Education:** MBBS/MD (Primary Care Physician), Kasturba Medical College, Manipal, MS in Engineering (Biodesign), Stanford University, MBA, The Wharton School, University of Pennsylvania
- **Known for:** Built and led a healthcare investment practice at Cota Capital ($1.5B vertical), backing breakthrough companies like Berkeley Lights and Mission Bio, Early investment in Berkeley Lights (Series E, $95M, 2018) and Mission Bio (Series B, $29M, 2018), Led product development of SaaS risk surveillance solutions for acute care published in peer-reviewed research

## Career timeline

- **Early career** — Trained and practiced as a Primary Care Physician
- **Mid career** — Consultant and advisor to health tech startups and Fortune 500 companies
- **Mid career** — Led Product Management for acute care products at Pieces Technologies (Parkland Center for Clinical Innovations), developing SaaS risk surveillance solutions
- **Mid career** — Associate Director of Commercial Strategy & Corporate Development at Natera, focused on biopharma partnerships and acquisitions
- **2018-2022** — Senior Associate / Principal at Cota Capital, built and led healthcare investment practice ($1.5B vertical), investing in Berkeley Lights, Zymergen, and Mission Bio
- **2023** — Joined Tarsadia Investments as Head of Healthcare Investments, leading VGP healthcare technology investments
- **2025-11** — Appointed Chief Business Officer at Hippocratic AI, leading commercial strategy across providers, payers, life sciences, and startups

## Achievements

- Built and led a healthcare investment practice at Cota Capital ($1.5B vertical), backing breakthrough companies like Berkeley Lights and Mission Bio
- Early investment in Berkeley Lights (Series E, $95M, 2018) and Mission Bio (Series B, $29M, 2018)
- Led product development of SaaS risk surveillance solutions for acute care published in peer-reviewed research
- Named as key executive hire at Hippocratic AI as it reached $3.5B valuation following $126M Series C
- Champion of gender-balanced teams and inclusive company cultures in healthcare technology
- Recognized as key thought leader in healthcare technology at the intersection of medicine, engineering, and investment

## Latest updates

- **2025-11** — Appointed Chief Business Officer at Hippocratic AI following the company's $126M Series C raise at a $3.5B valuation
- **2025-11** — Hippocratic AI announced accelerated team growth and key executive hires including Shubhra Jain
- **2023-09** — Joined Tarsadia Investments as Head of Healthcare Investments, leading VGP healthcare technology practice

## Links

- Website: https://hippocraticai.com
- LinkedIn: https://www.linkedin.com/in/drshubhra/

---

Profile page: https://yespress.io/shubhra-jain
Published by YesPress — https://yespress.io
Last updated: 2026-05-11